Extragonadal GCT (EGCT) carry a poorer prognosis than their gonadal counterparts and patients with a primary mediastinal non-seminomatous germ cell tumour (MNSGCT) are defined as poor risk in the IGCCCG prognostic category with a 48% 5-year survival [8].